Gendel receives €3.3m funding

Coleraine biotechnology company has secured €3.3m in third round funding in a round led by venture capital company Crescent Capital. Other investors included Enterprise Equity [NI], Scottish Equity partners and Danish investment fund PVJ.

Originally based on the University of Ulster's Coleraine campus, the company received initial funding of €1.47m in March 1999 from 3iGroup, businessman Alan Patterson and the Northern Ireland government, including funds through LEDU.